Drugs / Gonasi HP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06481696 Background | Jun 2024 → Dec 2025 | infertility disorder | Andros Day Surgery Clinic | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gonasi HP | “Highly purified urinary hCG (Gonasi HP, IBSA Farmaceutici, Italy) 10.000 IU, subcutaneously or intramuscularly, will be used to induce final oocyte maturation” NCT06481696 ↗ |
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06481696 ↗ |